Verrica Pharmaceuticals Inc. Begins Phase 3 Trial of VP-102 for Molluscum Contagiosum

Verrica Pharmaceuticals Inc

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that Torii Pharmaceutical Co., Ltd. recently dosed the first patient in its Phase 3 trial of VP-102 (referred to as TO-208 in Japan) for molluscum contagiosum in Japan, triggering an $8 million milestone payment from Torii to Verrica.

“We are pleased to see Torii dose the first patient in its Phase 3 trial of VP-102 for the treatment of molluscum contagiosum in Japan,” said Ted White, Verrica’s President and Chief Executive Officer. “The prevalence of molluscum contagiosum in Japan is estimated at 1.6 million cases annually, and we look forward to continuing our partnership with Torii in the Japanese market to potentially address this unmet need.”

In March 2021 Torii exercised its option to acquire the exclusive license to develop and commercialize Verrica’s product candidates for the treatment of molluscum contagiosum and common warts in Japan. Under the terms of the License Agreement, Torii made up-front payments of an aggregate of $12.0 million (including the original cost of acquiring the option) with up to an additional $58 million in aggregate payments contingent on achievement of specified development, regulatory, and sales milestones, in addition to tiered transfer price payments for supply of product in the percentage range of the mid-30s to the mid-40s of net sales. Torii is responsible for all development activities and costs in support of obtaining regulatory approval in Japan.

READ:  Zynerba Pharmaceuticals Reports Second Quarter 2022 Financial Results

Related Articles

Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.